Medical WeightLoss Malta

Ozempic (semaglutide) is a GLP-1 receptor agonist, a prescription medication that mimics a naturally occurring hormone in your body. It signals your brain to feel full sooner, reduces appetite and food noise, and slows gastric emptying, making it easier to eat less without the constant battle with hunger. At Carisma, Ozempic is always prescribed as part of a structured, doctor-led programme, never as a standalone prescription.

The programme is for adults who feel stuck with their weight and want a safe, clinically guided solution with Ozempic or Mounjaro. Many clients are in their thirties, forties, and fifties, juggling stress, work, family, and sometimes hormonal changes. You do not have to be a certain age. We look at your health, goals, and capacity, then tell you honestly whether GLP-1 medication is the right fit.

If you qualify and follow the programme, our patients lose on average around 1 kg per week. Clinical trials show average weight loss of 10–15% of body weight with Ozempic and 15–22% with Mounjaro over 12–18 months. Your results depend on starting weight, body composition, health, programme length, and adherence. We track progress with body scans and measurements, not just the scale.

In your assessment you sit with our doctor and go through your medical history, medications, past diets, and any hormonal or metabolic concerns. We take clinical measurements and perform a body-composition scan, and may recommend blood tests, blood-pressure checks, or food-intolerance testing. Many clients already manage conditions like high blood pressure, thyroid issues, or early diabetes, that is exactly why we screen properly and adapt your Ozempic or Mounjaro plan around your safety.

You will have structure, not a prison. We use a Mediterranean-style framework with enough protein, vegetables, and healthy fats, then fit it to your culture and lifestyle, planning for weekends, events, and eating out. No food is automatically banned. The focus is on what you can consistently follow, which matters even more on Ozempic or Mounjaro, where appetite is reduced and every meal needs to count nutritionally.

The most common side effects are gastrointestinal, nausea, constipation, diarrhoea, and fatigue, and are usually temporary, occurring in the early weeks as your body adjusts. We manage these through slow dose titration, protein-first nutrition, hydration protocols, and regular doctor reviews. Serious side effects are rare when the medication is prescribed appropriately and monitored closely, which is why ongoing medical supervision is a non-negotiable part of our programme.

Both are GLP-1 medications used for weight loss, but they work differently. Ozempic (semaglutide) targets GLP-1 receptors only, while Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors, a dual-action mechanism that may offer stronger appetite suppression. In clinical trials, Mounjaro showed average weight loss of 15–22% compared with 10–15% for Ozempic. Our doctor recommends the right medication based on your medical assessment, not marketing trends.

Yes. Ozempic is available in Malta by prescription. At Carisma Aesthetics, our doctors can prescribe Ozempic or Mounjaro after a full medical assessment confirms eligibility. We manage the prescription, dosing, and monitoring in-clinic, so you do not need to navigate pharmacies or dosage changes on your own.

Ozempic and Mounjaro costs depend on the dose you need, the length of your programme, and any complementary treatments included. We are fully transparent: you receive a clear plan and pricing in your consultation before starting, and we can discuss payment options to spread your investment. Contact us for current Ozempic and Mounjaro pricing in Malta.

No. Ozempic and Mounjaro are tools, not lifelong commitments. Our programme includes a defined maintenance phase and exit strategy, building the habits, nutrition structure, and movement routine you need to maintain results after stepping down from medication. Research shows that stopping GLP-1 medication without a structured plan often leads to weight regain, which is why we include a post-medication protocol.

Ozempic face describes the facial volume loss, sagging, and hollowness some patients experience during rapid weight loss on GLP-1 medications. We prevent this by controlling the pace of weight loss, prioritising protein to preserve facial fullness, and offering collagen-stimulating treatments and dermal fillers if needed. Being an aesthetics clinic and a GLP-1 programme under one roof means we treat the whole picture, body and face.

Yes, and this is one of the key advantages of doing your GLP-1 programme at Carisma Aesthetics. While Ozempic or Mounjaro helps you lose weight, treatments such as muscle stimulation, fat freezing, and skin tightening shape and refine your body as it changes. Your treatment plan is tailored to your body composition and goals, never a one-area-fits-all offer.

Getting a prescription is easy; building a programme that delivers lasting results is not. At Carisma, your Ozempic or Mounjaro prescription is one part of a wider system: medical monitoring, personalised nutrition, strength-training guidance, weekly accountability, body-contouring treatments, aesthetics support for Ozempic-face prevention, and a defined exit strategy. We do not prescribe and forget, we guide you through every phase.